Terms: = Thyroid cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
11 results:
1. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
[TBL] [Abstract] [Full Text] [Related]
2. The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells.
Abutorabi ES; Poursheikhani A; Kashani B; Shamsaiegahkani S; Haghpanah V; Bashash D; Mousavi SA; Momeny M; Ghaffari SH
Mol Biol Rep; 2023 May; 50(5):4073-4082. PubMed ID: 36877344
[TBL] [Abstract] [Full Text] [Related]
3. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.
Zhao J; Li D; Fang L
Biomed Pharmacother; 2019 Jul; 115():108947. PubMed ID: 31078043
[TBL] [Abstract] [Full Text] [Related]
4. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/cdk6 axis.
Zhang H; Zhao B; Wang X; Zhang F; Yu W
Life Sci; 2019 Jul; 228():135-144. PubMed ID: 31047896
[TBL] [Abstract] [Full Text] [Related]
5. SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid cancer.
Kim SY; Kim SM; Chang HJ; Kim BW; Lee YS; Park CS; Park KC; Chang HS
BMC Cancer; 2018 Oct; 18(1):956. PubMed ID: 30286728
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of pain during high-intensity focused ultrasound ablation of benign thyroid nodules.
Lang BHH; Woo YC; Chiu KW
Eur Radiol; 2018 Jun; 28(6):2620-2627. PubMed ID: 29330630
[TBL] [Abstract] [Full Text] [Related]
7. Disparities in the Care of Differentiated thyroid cancer in the United States: Exploring the National cancer Database.
Jaap K; Campbell R; Dove J; Fluck M; Hunsinger M; Wild J; Arora T; Shabahang M; Blansfield J
Am Surg; 2017 Jul; 83(7):739-746. PubMed ID: 28738945
[TBL] [Abstract] [Full Text] [Related]
8. BRAF V600E detection in cytological thyroid samples: A key component of the decision tree for surgical treatment of papillary thyroid carcinoma.
Collet JF; Lacave R; Hugonin S; Poulot V; Tassart M; Fajac A
Head Neck; 2016 Jul; 38(7):1017-21. PubMed ID: 26854757
[TBL] [Abstract] [Full Text] [Related]
9. Clinic-based ultrasound can predict malignancy in pediatric thyroid nodules.
Goldfarb M; Gondek SS; Sanchez Y; Lew JI
Thyroid; 2012 Aug; 22(8):827-31. PubMed ID: 22780453
[TBL] [Abstract] [Full Text] [Related]
10. The natural history of thyroid function abnormalities after treatment for childhood cancer.
Madanat LM; Lähteenmäki PM; Alin J; Salmi TT
Eur J Cancer; 2007 May; 43(7):1161-70. PubMed ID: 17391953
[TBL] [Abstract] [Full Text] [Related]
11. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract] [Full Text] [Related]
